| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0006 |